Rare diseases
Investigational molecules
Locations
Back to Czechia1 217 clinical trials in Prague, Czechia across 18 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)CzechiaLong-Term Study for Cancer Patients Using Atezolizumab Therapy
CzechiaStudy of Isatuximab, Lenalidomide, and Dexamethasone for Patients with High-Risk Smoldering Multiple Myeloma
CzechiaStudy of Rilzabrutinib for Adults with Relapsed Immune Thrombocytopenia
CzechiaStudy of Ibrutinib and Rituximab for Patients with Follicular Lymphoma
CzechiaStudy of LY3556050 for Adults with Diabetic Peripheral Neuropathy Pain
CzechiaStudy on the Safety and Effectiveness of Baricitinib and Tocilizumab for Children with Systemic Juvenile Idiopathic Arthritis
CzechiaStudy of Bemarituzumab with Chemotherapy and Nivolumab in Untreated Advanced Gastric and Gastroesophageal Junction Cancer Patients with FGFR2b Overexpression
CzechiaStudy of Bemarituzumab and Chemotherapy for Patients with Advanced Stomach or Gastroesophageal Cancer with FGFR2b Overexpression
CzechiaStudy on Adding Apalutamide to Radiotherapy and LHRH Agonist for High-Risk Patients with Hormone-Sensitive Prostate Cancer
CzechiaStudy on Xevinapant and Radiotherapy for High-Risk Head and Neck Cancer Patients Unable to Take High-Dose Cisplatin
CzechiaStudy on the Effectiveness and Safety of Durvalumab with Gemcitabine and Cisplatin for Patients with Muscle-Invasive Bladder Cancer
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on TTR amyloidosis and heart disease treatments, alongside studies investigating hypertriglyceridemia management with novel therapeutics.
Multiple trials evaluating new therapeutic approaches for heart failure prevention and treatment.
Comprehensive studies in prostate cancer and multiple myeloma, with particular focus on metastatic conditions and novel treatment combinations.
Advanced trials comparing innovative therapies against standard treatments in various cancer types.
Extensive vaccine development programs including meningococcal and chickenpox vaccines, alongside studies in immune system disorders.
Focus on immunogenicity and safety in various age groups from infants to adults.
Research into chronic rhinosinusitis and COPD, along with studies on inflammatory bowel conditions.
Evaluating new therapeutic approaches for chronic respiratory and inflammatory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
